FND Education Project

REFERENCE · RECOVERY TECHNIQUE

Graded Activity and Reconditioning for Functional Limb Weakness

Most likely fit: Reduced use has added loss of strength, endurance, confidence or ordinary activity tolerance to the functional weakness, and a repeatable baseline can be identified without unacceptable immediate or delayed worsening. [Clinical consensus; rehabilitation-programme evidence does not establish one dosing formula]

Dosing boundary: “Graded” means deliberately adjusted from the person’s current response. It does not mean automatic increases, exercising through deterioration or assuming every symptom increase is harmless.

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For the Person With FND

What reconditioning can and cannot do

Less activity can lead to deconditioning—real changes in muscle capacity, cardiovascular fitness and tolerance of upright activity. Reconditioning can address those changes and create more opportunity to practise functional movement. It is not proof that deconditioning caused the FND, and it does not mean that every increase in weakness, pain or fatigue should be pushed through.

Anatomy in everyday language

Muscle force depends on the size and recruitment of muscle fibres, but activity also depends on heart and lung response, blood-pressure regulation, joint tolerance, balance and recovery. Post-exertional symptom worsening means symptoms rise after activity, sometimes later rather than during the session. A plan must look beyond what was possible in the moment.

Building a responsive baseline

Choose one meaningful activity and a dose that can usually be repeated: time, repetitions, distance, resistance or task steps. Record the immediate response, later that day and the following day when delayed worsening is part of the pattern. Repeat the baseline before changing it. Increase one variable only when the previous level remains useful and tolerable; reduce or redistribute it when recovery cost is too high.

Some discomfort or effort can be acceptable, but the plan should define what is expected and what means stop. New neurological symptoms, chest pain, fainting, severe breathlessness, injury or a major change from the established pattern needs assessment.

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For Family, Friends, and Other Supporters

Help protect the repeatable plan from both pressure and good-day overexpansion. Do not equate a temporary increase with progress or a reduction with failure. Support practical pacing: transport, task sharing, a place to sit and a plan for the rest of the day. Notice participation and recovery time, not only exercise totals.

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For Clinicians and the Care Team

Assessment before prescription

Separate the motor-control target from secondary conditioning needs. Review cardiopulmonary status, orthostatic symptoms, pain, joint stability, medication effects, sleep, nutrition, falls, migraine, fatigue and coexisting conditions. Ask specifically about immediate and 24–48-hour response where delayed worsening is reported. Do not infer safety from one clinic session.

Anatomy and physiology

Strength practice loads muscle and tendon; endurance practice challenges oxidative metabolism and cardiopulmonary delivery; upright practice also challenges autonomic and skeletal-muscle pump responses. Functional movement retraining addresses access and coordination and is not interchangeable with progressive resistance training. Translate the distinction: “This task practises the movement pattern; this separate dose rebuilds what reduced activity has taken away.”

Explicit dosing sequence

  1. Select a functional outcome and the conditioning component relevant to it.
  2. Establish baseline variability across several days when feasible. Record activity dose, symptoms, assistance and recovery.
  3. Choose a submaximal, repeatable starting dose. Specify frequency, intensity, time, type and stopping criteria.
  4. Preserve movement quality and external task focus. Use interval practice, position change or assistive equipment when these reduce unnecessary cost.
  5. Review immediate, same-day and delayed effects. Distinguish expected short-lived exertion from sustained loss of function or a broader flare.
  6. Progress one variable only after the baseline is repeatable. If response is unacceptable, reduce, divide, alternate or change the task rather than blaming adherence.
  7. Re-test the meaningful activity; conditioning gains matter when they improve participation, safety or quality of life.

Persistent, episodic and post-exertional patterns

For persistent weakness, build consistency before intensity. For episodic weakness, retain a lower-demand version for flare days and define the route back. When post-exertional worsening is present or a condition such as ME/CFS is suspected or diagnosed, use condition-appropriate assessment and energy management; do not import a fixed-increment exercise model. Evidence from ME/CFS pacing literature is adjacent, heterogeneous and not proof for FND, but it reinforces the need to avoid a universal formula. [4]

Measures and evidence boundary

Record the activity that matters, dose, assistance, falls, symptoms, recovery time and participation. Strength, sit-to-stand, gait speed or endurance measures can add information when safe. The large Physio4FMD trial did not show a significant advantage on the primary 12-month physical-function outcome, although some secondary and patient-rated outcomes favoured specialist treatment. Do not promise that a graded programme or one dosing method will work for every person. [1][2][3]

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

Research and Sources

Citation Full citation
[1] Nielsen G, Stone J, Matthews A, et al. Physiotherapy for functional motor disorders: a consensus recommendation. Journal of Neurology, Neurosurgery & Psychiatry. 2015;86(10):1113–1119. FND-CIT-0028. https://doi.org/10.1136/jnnp-2014-309255
[2] Nielsen G, Stone J, Lee TC, et al. Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD). The Lancet Neurology. 2024;23(7):675–686. FND-CIT-0029. https://doi.org/10.1016/S1474-4422(24)00135-2
[3] Nicholson C, Edwards MJ, Carson AJ, et al. Occupational therapy consensus recommendations for functional neurological disorder. Journal of Neurology, Neurosurgery & Psychiatry. 2020;91(10):1037–1045. FND-CIT-0011. https://doi.org/10.1136/jnnp-2019-322281
[4] Sanal-Hayes NEM, McLaughlin M, Hayes LD, et al. A scoping review of pacing for ME/CFS. Journal of Translational Medicine. 2023;21:720. This adjacent evidence does not establish FND treatment. FND-CIT-0066. https://doi.org/10.1186/s12967-023-04587-5

Detailed technique page created: September 10, 2026 · Clinical and accessibility review pending

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —